SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 6.87 |
| Enterprise Value ($M) | 15.89 |
| Book Value ($M) | -6.77 |
| Book Value / Share | -6.03 |
| Price / Book | -1.02 |
| NCAV ($M) | -31.31 |
| NCAV / Share | -27.87 |
| Price / NCAV | -0.22 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.34 |
| Return on Assets (ROA) | -0.99 |
| Return on Equity (ROE) | -3.43 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.19 |
| Current Ratio | 0.19 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 5.70 |
| Assets | 30.24 |
| Liabilities | 37.01 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2.57 |
| Operating Income | -29.48 |
| Net Income | -30.02 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -14.23 |
| Cash from Investing | -0.26 |
| Cash from Financing | 15.57 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Wong Hing C | 36.04 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 31,915 | 111,851 | 28.53 | |
| 6,589 | 14,004 | 47.05 | |
| 1,151 | 6,299 | 18.27 | |
| 6,306 | 12,281 | 51.35 | |
| 11,674 | 37,651 | 31.01 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GRCE – Grace Therapeutics, Inc. | GTBP – GT Biopharma, Inc. |
| GYRE – Gyre Therapeutics, Inc. | HEPA – Hepion Pharmaceuticals, Inc. |
| HOOK – HOOKIPA Pharma Inc. |
Financial data and stock pages provided by
Fintel.io